Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Menthol-based microemulsions improve skin delivery of finasteride and silodosin.

Minoxidil sulfate relaxes blood vessels by increasing potassium permeability.

NXC736 significantly reduced hair loss in mice with alopecia areata.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

The new compound may be a safer alternative to finasteride for prostate protection.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Finasteride and dutasteride's effects are mainly due to target binding saturation and slow enzyme turnover.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Diphenyl ethers can potentially reduce excess oil production when applied on the skin, helping treat conditions like acne.

Spanlastic nano-vesicles improve famotidine's effectiveness and absorption.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

New compounds may help treat prostate issues without affecting androgen receptors.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

GD-23 reduces anxiety by relying on neurosteroid production.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

A new compound shows promise as a topical treatment for hair loss.